Delivery Order SPE2DB22D1202-SPE2DB24FUTX5
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The order is for Dupixent 300 mg/2 ml pen, with a ceiling value of $12,448.54 and a completion date of March 22, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product Dupixent 300 mg/2 ml pen, with a ceiling value of $17,092.99 and a performance period through March 21, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Dupixent 300 mg/2 ml pens. The delivery order, valued at $1,871.17, was issued under an Indefinite Delivery Contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $7,452.32 order is for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen, with an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company to provide a wide...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract is for the provision of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product, with a ceiling value of $35,629.05 and a performance period through March 26, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) with a potential...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen, 2 ml. The contract has a firm fixed price of $6,609.44 and a completion date of May 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 300 mg/2 ml Pen 2 ml, a specialty pharmaceutical product, with a ceiling value of $16,026.33 and a period of performance through March 20, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution and services company, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product, with a ceiling value of $9,788.80 and a performance period through March 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml pen 2 ml. The contract is a firm fixed-price delivery order with a ceiling value of $58,613.48 and a period of performance through April 23, 2025. This award is not set-aside and represents an open competition contract vehicle. AmerisourceBergen Drug Corp is the prime contractor, and there is no information provided...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen. The contract has a ceiling value of $19,846.33 and a completion date of April 19, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUTX5Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Dupixent 300 mg/2 ml pen, a pharmaceutical product, with a ceiling value of $6,829.41 and a period of performance through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor on an Indefinite Delivery Contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order awarded is a task order issued under this IDC. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 3/15/24 |